Overview of magnetic resonance imaging for management of relapsing−remitting multiple sclerosis in everyday practice

• Published in: European journal of neurology Vol. 22; no. S2; pp. 22 - 27
• Main Author: Oreja-Guevara, C.
• Format: Journal Article
• Language: English
• Published: England Blackwell Publishing Ltd 01.10.2015; John Wiley & Sons, Inc
• Subjects: diagnosis; Disease Progression; disease-modifying therapy; Humans; magnetic resonance imaging; Magnetic Resonance Imaging - methods; Magnetic Resonance Imaging - standards; Multiple sclerosis; Multiple Sclerosis, Relapsing-Remitting - diagnosis; Multiple Sclerosis, Relapsing-Remitting - therapy; neuroimaging; NMR; Nuclear magnetic resonance; Outcome Assessment (Health Care) - methods; Outcome Assessment (Health Care) - standards; prognosis; diagnosis; magnetic resonance imaging; prognosis; multiple sclerosis; disease-modifying therapy; neuroimaging
• ISSN: 1351-5101; 1468-1331
• DOI: 10.1111/ene.12800

Although the value of magnetic resonance imaging (MRI) for diagnosis/differential diagnosis of patients with clinically isolated syndromes suggestive of multiple sclerosis (MS) is widely accepted, adoption of MRI into clinical practice to monitor disease evolution remains a work in progress. However, an accumulating body of evidence points to a central role for MRI in managing patients with relapsing−remitting MS along the disease continuum. Routine MRI surveillance provides insight into disease activity that is not evident clinically and this information, in turn, can be used to inform prognosis and guide treatment decisions. In Europe, practical guidelines have been developed to reduce the heterogeneity of imaging (both intracentre and intercentre) and improve the quality of MRI assessment and interpretation. Aimed at the general neurologist, this review explores some of the issues associated with MRI and examines evidence supporting its use for routine monitoring of MS patients in everyday practice.